Jonghwa Won

Yonsei University — South Korea

Medicine · Health Sciences

22h-index1.2kcitations92works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(35), HER2/EGFR in Cancer Research(24), Colorectal Cancer Treatments and Studies(14), CAR-T cell therapy research(13), Radiopharmaceutical Chemistry and Applications(12)

Publications92 total

Abstract 6084: YH32364 (ABL104), a bispecific antibody against EGFR and 4-1BB, demonstrates potent anti-tumor efficacy through tumor-directed 4-1BB agonism
Cancer Research·2025· 1 cited
Abstract 5811: ABL103, a bispecific antibody targeting B7-H4 and 4-1BB, shows synergistic immune responses with combination of pembrolizumab in the immunosuppressive tumor microenvironment
Cancer Research·2025
CLEC12A-directed immunocytokine with target cell–restricted IL-15 activity for treatment of acute myeloid leukemia
Frontiers in Immunology·2025Open Access
Abstract No. 22 First Experience of Irreversible Electroporation for Locally Advanced Pancreatic Cancer Using Clustered Electrodes
Journal of Vascular and Interventional Radiology·2025Open Access
Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8<sup>+</sup> T cell activity and Fcγ receptor-mediated modulation of the tumor microenvironment
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Abstract 5304: ABL407, a LILRB4x4-1BB bispecific antibody with a wild type Fc, exhibits potent antitumor activity by modulating immune system in multiple ways involving T cells, myeloids, and regulatory T cells
Cancer Research·2024
Abstract 5303: A novel TIGIT and 4-1BB bispecific antibody, ABL112, exhibits potent in vitro and in vivo antitumor activity through dual immune modulation
Cancer Research·2024· 1 cited
Abstract 6354: The HER2/4-1BB bispecific antibody, YH32367 (ABL105) demonstrates optimal efficacy and safety for HER2-expressing tumors and exhibits synergistic efficacy when combined with anti-PD-L1
Cancer Research·2024· 2 cited
Bone Marrow Edema Syndrome of the Hip
2024
Distinguishing Bone Marrow Edema Syndrome from Osteonecrosis
2024
Accumulation of Necrotic Fatty Marrow in Osteonecrotic Hips Mimicking Septic Arthritis
2024
Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release
Journal for ImmunoTherapy of Cancer·2023· 12 citedOpen Access
Abstract 2941: ROR1 targeted 4-1BB costimulatory bispecific antibody, ABL102, exhibits potent <i>in vitro</i> and <i>vivo</i> antitumor activity and superior safety profile
Cancer Research·2023
Data from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary figure 2 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary table 2 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary method from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary table 1 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary figure 1 from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
Supplementary method from GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Seog Bae Oh(8), Kyeongsu Park(6), Yangmi Lim(6), Yangsoon Lee(6), Minkyu Hur(6), Eun Young Park(5), Ui-jung Jung(4), Hanbyul Lee(4), Yong-Gyu Son(4), Jaeho Jung(4), Yun‐Gyoung Hur(4), Keun‐Hyeung Lee(4), Shinai Lee(4), Wonjun Son(4), Hongtae Kim(3), Eun-Sil Sung(3), Youngeun Hong(3), See‐Hyoung Park(3), Mi‐Ae Kang(3), Kyuhyun Lee(3)